MS STUDENTS: QUESTIONS TO KNOW SECTION. Flurbiprofen misspelled!

Slides:



Advertisements
Similar presentations
Assignment 6 Metabolism
Advertisements

HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Distribution & Fate Lesson 5. Distribution n Drug disperses throughout system l does not reach target l silent receptors n Distributes in l Blood & extracellular.
3 Phases Provide a functional group (e.g. OH or NH 2 ) to: increase polarity of the drug provide a site for phase II reactions.
Module 2 # 2 Pharmacokinetics absorption of drugs drugs can be given iv, im, sc, orally (po) if given parenterally, they should.
DISTRIBUTION The body is a container in which a drug is distributed by blood (different flow to different organs) - but the body is not homogeneous. Factors.
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Drug Handling in kidney and liver disease
Practical Pharmacokinetics
Drug Metabolism Overview Dr. Arthur Roberts 1. Where to Find Information eLC – most up to date – correct errors 2.
Pharmacokinetics: Bioavailability Asmah Nasser, M.D.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
Review of Pharmacokinetics
Mechanisms of Toxicity
Pharmacology Department
LONGITUDNAL SECTION OF KIDNEY KLECOP, Nipani.
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Prof. Hanan Hagar Dr.Abdul latif Mahesar Pharmacology Department Pharmacokinetics III Concepts of Drug Disposition.
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Pharmacokinetics Introduction
PHARMACOKINETICS.
From A Physiologic Perspective Chemical Clearance from the Body
Mrs. Wharton’s Science Class.  System of the body that collects wastes produced by cells and removes the wastes from the body.  Excretion- what the.
Absorption, Distribution, Metabolism and Elimination (ADME)
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
PHARMACOKINETICS Part 3.
One Compartment Open Model IV bolus
Lecture 8. The body is a container in which a drug is distributed by blood (different flow to different organs) - but the body is not homogeneous. Factors.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Section 1, Lecture 4 Phase I reactions-oxidative occur in the endoplasmic reticulum of liver (microsomal fractions) - catalyzed by the microsomal.
Clearance Determinations Arthur G. Roberts. Routes of Elimination.
Errata Lecture 10 Slide 18 Rational because However.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Pharmacology Department
Phoenix WinNonLin Assignment Due Today Access Phoenix remotely.
Concepts of drug disposition Pharmacology Department
MS Phoenix WinNonLin Project
MS WinNonLin Assignment
INTRODUCTION Lecture 2.
Clarifications of Lecture #36- Drug Interactions I
Metabolic Stability Lee, Sang-Hwi. -2- Overview Metabolism is the enzymatic modification of compounds to increase clearance. It is a determinant.
Study Aids Anki Flash cards – Content that you need to know for the tests. MS Excel sheet with Calculations.
Lecture 2 Clearance, maintenance dose and AUC
The General Concepts of Pharmacokinetics and Pharmacodynamics
Clearance and Renal Excretion Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk,
Clearance: basic concept (in vitro) Update OCT 2010.
Pharmacokinetics 2 General Pharmacology M212
Pharmacology I BMS 242 Lecture 4 Pharmacokienetic Principles (3&4): Drug Metabolism and Excretion [Elimination] Dr. Aya M. Serry 2016.
Foundation Knowledge and Skills
METABOLISME DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA dr. Yunita Sari Pane.
Hepatic Clearance Course Title : Biopharmaceutics and Pharmacokinetics – I.
Course Title : Biopharmaceutics and Pharmacokinetics – I
Intrinsic Clearance Arthur G. Roberts. Hydrophobic vs. Hydrophilic more bound to plasma proteins more distributed throughout body more metabolized.
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetics.
Allie punke Pharmacokinetics tutoring Fall 2016
Allie punke Pharmacokinetics tutoring Fall 2016
Quantitative Pharmacokinetics
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Clinical Pharmacokinetics
BIOAVAILABILITY.
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Presentation transcript:

MS STUDENTS: QUESTIONS TO KNOW SECTION

Flurbiprofen misspelled!

PROCESSES OF ELIMINATION AND CLEARANCE Lecture #9

CYP = Cytochrome P450 UDPG = UDP glucuronosyltransferase

Pathways of Drug Metabolism Oxidation and Reduction Conjugation Drugs 5

Phase I versus Phase II? 6 A B C D

Functions Good – Drug Clearance – Toxin Removal* – Homeostasis and Regulation* – Prodrug (inactive)  Active Drug* Bad -Reduced Efficacy -Increased Toxicity* 7

Functions: Toxin Removal bisphenol A Sulfonation Glucuronidation 8

Functions: Homeostasis and Regulation 9

Functions: Prodrug  Drug Antidepressant Antihistamine (Fura et al., 2004) Antihistamine Analgesic 10

Functions: Increased Toxicity Toxic Pathway 11

Abundance Contributions

Elimination Rate Example Midazolam: Dose = 7.5 mg CL = 28 L/hr V = 140 L C V =A/V = 7.5 mg/140 L = 0.05 mg/L Rate of Elimination (mg/hr) = 28 L/hr * 0.05 mg/L = 1.4 mg/hr

Extraction Rate and Extraction Ratio

=1 =E Extraction Rate Units = mg/hr

Fraction Remaining Q* Extraction Ratio Units = Unitless

Clearance Units= L/hr

Clearance Kidneys Liver Blood Flow (Q) Q H =Q R =1 L/hr/kg Q H =Q R =70 L/hr

Clearance Organ – Hepatic (liver) – Renal (kidneys) – Pulmonary (lungs) Process – renal/extrarenal – metabolic and excretory clearance Site of Measurement – reference fluid (blood vs. plasma clearance)

Additivity of Clearance Rate of Elimination Rate of Renal Excretion Rate of Hepatic Metabolism Rate of Biliary Excretion Rate of Other = % 6%69% <1% Not Shown On Pie Chart CYP = cytochrome P450 UDP = UDP glucuronsyltransferases

Additivity of Clearance Rate of Elimination Rate of Renal Excretion Rate of Hepatic Metabolism Rate of Biliary Excretion Rate of Other = % 6%69% <1%

Additivity of Clearance Rate of Elimination Rate of Renal Excretion Rate of Hepatic Metabolism Rate of Biliary Excretion Rate of Other = % 6%69% <1% CVCV CVCV CVCV CVCV CVCV ~6%

Elimination Rate System Circulation Elimination rate CVCV CuCu C blood Assumption: Rapid equilibria between blood, plasma, bound and unbound.

Plasma versus Blood Clearance Binding of drugs to drug-binding proteins in the plasma. Binding to blood cells extensive. = 0.3 to 2.0

Plasma versus Blood Clearance DrugC V, µMC blood, µMC V /C blood Indomethacin Loperamide Moxalaction DrugC V /C blood Amytriptyline1.13 Imipramine1.17 Nortriptyline1.67 Maprotiline2.23 Nomifensine1.21 Diazepam0.71

Plasma versus Blood Clearance Example Verapamil: Plasma/Blood ratio = 1.29 CL = 9 L/hr/kg V = 4.3 L/kg A = mg/kg CL = 630 L/hr V= 301 L A= 10 mg Calculate C V C V =A/V=10 mg/301 L = mg/L Calculate C blood Plasma/Blood ratio=1.29=(0.033 mg/L)/C blood C blood = mg/L Calculate CL blood CL blood =CL*(C V /C blood ) CL blood =630 * 1.29 CL blood = L/hr

Total (CL) versus Unbound Clearance (CL U ) CL = 0.26 L/hr/kg CL = 18.2 L/hr (70 kg) f u = (i.e. ~95% bound) CL U =18.2/0.048 CL U =379 L/hr! tyrosine kinase inhibitor (anti-cancer)